SCHEMBL1903045

SCHEMBL1903045

C=C(CCCCCCC=CCC=CCC(C=O)CCCCCC)C(=O)O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.51
F7 P08709 4/20 0.51
F3 P13726 4/20 0.51
FFAR1 O14842 4/20 0.51
PPARG P37231 4/20 0.51
PPARD Q03181 3/20 0.51
PPARA Q07869 3/20 0.51
KDM4E B2RXH2 3/20 0.51
FABP3 P05413 3/20 0.51
FFAR4 Q5NUL3 2/20 0.51
PTGS1 P23219 2/20 0.51
DUSP3 P51452 1/20 0.51
PTPN7 P35236 1/20 0.51
LMNA P02545 1/20 0.51
CYP3A4 P08684 1/20 0.51
CYP19A1 P11511 1/20 0.51
FABP4 P15090 1/20 0.51
HPGD P15428 1/20 0.51
ALOX15 P16050 1/20 0.51
TSHR P16473 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1897348 0.88 FNTA (0.49) ALDH1A1F7F3FFAR1PPARG
SCHEMBL1834980 0.84 TRPV1 (0.53) ALDH1A1F7F3FFAR1PPARG
SCHEMBL4624538 0.84 ALDH1A1 (0.70) ALDH1A1F7F3FFAR1PPARG
SCHEMBL2526500 0.84 ALDH1A1 (0.70) ALDH1A1F7F3FFAR1PPARG
SCHEMBL17062994 0.83 FFAR1 (0.70) ALDH1A1F7F3FFAR1PPARG
SCHEMBL17062995 0.83 FFAR1 (0.70) ALDH1A1F7F3FFAR1PPARG
SCHEMBL1896642 0.83 FFAR4 (0.45) ALDH1A1FFAR1PPARGPPARDPPARA
SCHEMBL1897351 0.83 FFAR4 (0.45) ALDH1A1FFAR1PPARGPPARDPPARA
SCHEMBL1900176 0.83 FFAR4 (0.45) ALDH1A1FFAR1PPARGPPARDPPARA
SCHEMBL1905242 0.83 FFAR4 (0.45) ALDH1A1FFAR1PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2321254-B1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD EVONIK ROEHM GMBH (DE) 2014-07-30 EP disclosed
EP-2324069-B1 MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING EVONIK ROEHM GMBH (DE) 2013-12-18 EP disclosed
US-20110144267-A1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD EVONIK ROEHM GMBH (DE) 2011-06-16 US disclosed
EP-2324069-A1 MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING Evonik Röhm GmbH (DE) 2011-05-25 EP disclosed
WO-2010026118-A1 MONOMER MIXTURE, POLYMER, COATING MEANS AND METHOD FOR PRODUCING A COATING EVONIK RÖHM GMBH (DE) 2010-03-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144267-A1 FUNCTIONALIZED (METH)ACRYLATE MONOMER, POLYMER, COATING AGENT, AND PRODUCTION AND CROSS-LINKING METHOD DNMT1, TET1, MGMT ALDH1A1 55/4885F7 1042/4885F3 394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.